Nivolumab-related mucous membrane pemphigoid

被引：22

作者：

Sibaud, Vincent ^{[1
,2
]}

Vigarios, Emmanuelle ^{[2
,3
]}

Siegfried, Aurore ^{[2
,4
]}

Bost, Chloe ^{[5
]}

Meyer, Nicolas ^{[1
,2
,6
]}

Pages-Laurent, Cecile ^{[1
,2
]}

机构：

[1] Inst Claudius REGAUD, Oncodermatol Dept, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France

[2] Inst Univ Canc Toulouse Oncopole, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France

[3] Inst Claudius REGAUD, Dept Oral Med, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France

[4] Inst Claudius REGAUD, Dept Pathol, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France

[5] CHU, Dept Immunol, Toulouse, France

[6] CHU, Dept Dermatol, Toulouse, France

来源：

EUROPEAN JOURNAL OF CANCER | 2019年 / 121卷

关键词：

Nivolumab; Mucous membrane pemphigoid; BP180; Autoimmune blistering disorder; Gingivitis; AntiePD-1; DISORDERS;

D O I：

10.1016/j.ejca.2019.08.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：172 / 176

页数：5

共 16 条

[1] A Severe, Refractory Case of Mucous Membrane Pemphigoid After Treatment With Pembrolizumab: Brief Communication
Bezinelli, Leticia Mello
Eduardo, Fernanda P.
Migliorati, Cesar A.
Ferreira, Mariana H.
Taranto, Patricia
Sales, Diogo B.
Santi, Claudia G.
Macarenco, Ricardo S.
Godoy, Claudia P., V
Correa, Luciana
Buzaid, Antonio C.
[J]. JOURNAL OF IMMUNOTHERAPY, 2019, 42 (09) : 359 - 362
[2] Mucous membrane pemphigoid and oral blistering diseases
Carey, B.
Setterfield, J.
[J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (07) : 732 - 739
[3] Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma
Haug, V.
Behle, V.
Benoit, S.
Kneitz, H.
Schilling, B.
Goebeler, M.
Gesierich, A.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 993 - 994
[4] A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors
Lopez, Adriana T.
Khanna, Trisha
Antonov, Nina
Audrey-Bayan, Claire
Geskin, Larisa
[J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (06) : 664 - 669
[5] Desquamative gingivitis Clinical findings and diseases
Maderal, Andrea D.
Salisbury, Paul Lee, III
Jorizzo, Joseph L.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 839 - 848
[6] Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Menzies, A. M.
Johnson, D. B.
Ramanujam, S.
Atkinson, V. G.
Wong, A. N. M.
Park, J. J.
McQuade, J. L.
Shoushtari, A. N.
Tsai, K. K.
Eroglu, Z.
Klein, O.
Hassel, J. C.
Sosman, J. A.
Guminski, A.
Sullivan, R. J.
Ribas, A.
Carlino, M. S.
Davies, M. A.
Sandhu, S. K.
Long, G. V.
[J]. ANNALS OF ONCOLOGY, 2017, 28 (02) : 368 - 376
[7] Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
Naidoo, Jarushka
Schindler, Katja
Querfeld, Christiane
Busam, Klaus
Cunningham, Jane
Page, David B.
Postow, Michael A.
Weinstein, Alyona
Lucas, Anna Skripnik
Ciccolini, Kathryn T.
Quigley, Elizabeth A.
Lesokhin, Alexander M.
Paik, Paul K.
Chaft, Jamie E.
Segal, Neil H.
D'Angelo, Sandra P.
Dickson, Mark A.
Wolchok, Jedd D.
Lacouture, Mario E.
[J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (05) : 383 - 389
[8] Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMc1801663, 10.1056/NEJMra1703481]
[9] Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma
Schmidgen, Maria Isabel
Butsch, Florian
Schadmand-Fischer, Simin
Steinbrink, Kerstin
Grabbe, Stephan
Weidenthaler-Barth, Beate
Loquai, Carmen
[J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (07): : 742 - 745
[10] Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings
Sibaud, V.
Eid, C.
Belum, V. R.
Combemale, P.
Barres, B.
Lamant, L.
Mourey, L.
Gomez-Roca, C.
Estilo, C. L.
Motzer, R.
Vigarios, E.
Lacouture, M. E.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (10) : E464 - E469

← 1 2 →